Targeting metabolism to modify cirrhosis: Lessons from FGF21 therapy in MASH. Luukkonen PK. J Hepatol 2026 Mar 19:S0168-8278(26)00131-5. doi: 10.1016/j.jhep.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Luukkonen PK. Targeting metabolism to modify cirrhosis: Lessons from FGF21 therapy in MASH. J Hepatol 2026 Mar 19:S0168-8278(26)00131-5. doi: 10.1016/j.jhep.2026.
PMID: 41862318